Our tech helps patients double their weight loss with fewer side effects than conventional interventions (i.e. diet, meds, devices, surgery.)
Founded by 2 obesity doctors using exclusive tech from Mayo Clinic (patents pending).
The blood test has been clinically validated in 2 randomized controlled Mayo Clinic trials to predict obesity drug response at 90% accuracy.
Selected by the National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program for breast cancer.
Founder has taken 10 approved drugs to the FDA & EMA and failed only once.
Received $3.7MM grant from EU supported fund in Poland for Triple Negative Breast Cancer Treatment.
Privacy: We won’t share your data, or post to your wall, without your permission.
Already have an account? Login
Don't have an account? Signup